Blood Pressure Monitoring and Measurement Instruments: Global Strategic Business Report

Global Blood Pressure Monitoring and Measurement Instruments Market to Reach $4.3 Billion by 2030

The global market for Blood Pressure Monitoring and Measurement Instruments estimated at US$2.1 Billion in the year 2022, is projected to reach a revised size of US$4.3 Billion by 2030, growing at a CAGR of 9.3% over the analysis period 2022-2030. Sphygmomanometers, one of the segments analyzed in the report, is projected to record 7.1% CAGR and reach US$1.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Automated / Digital Blood Pressure Monitor segment is readjusted to a revised 11.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $573.5 Million, While China is Forecast to Grow at 13.3% CAGR

The Blood Pressure Monitoring and Measurement Instruments market in the U.S. is estimated at US$573.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$957.5 Million by the year 2030 trailing a CAGR of 13.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.1% and 7.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Select Competitors (Total 46 Featured) -

• A&D Medical
• American Diagnostic Corporation
• Beurer GmbH
• Bokang Instruments Co., Ltd.
• Briggs Healthcare
• Draegerwerk AG & Co., KGaA
• GE Healthcare Ltd.
• GF Health Products Inc.
• HealthSTATS International Pte Ltd.
• iHealth Labs, Inc.
• Jitron Pte Ltd.
• Medel International srl
• Microlife AG
• Omron Healthcare Co., Ltd.
• Philips Healthcare
• Rossmax International Ltd.
• Shenzhen Kingyield Technology Co., Ltd.
• Spacelabs Healthcare Inc.
• SunTech Medical Inc.
• Welch Allyn Inc.
• Withings

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year